2m 2m 2m 2m 2m 2m 2m
Vertex Pharma (VRTX)
NASDAQ
$555.14+$8.11 (+1.48%)
Price as of Nov 12, 2026 8:57 AM EST- $138.7BMarket Cap
- 25.99%1-Year Change
- BiotechnologyIndustry
Vertex Pharma (VRTX)
$555.14+$8.11 (+1.48%)
VRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $547.03 | ||
Change | -$0.86 (-0.16%) | ||
Open | $543.96 | ||
High | $548.67 | ||
Low | $535.46 | ||
Previous Close | $547.89 | ||
Volume | 1,077,750 | ||
30-Day Average Volume | 1,616,244 | ||
1-Week Change | -0.37% | ||
1-Month Change | 7.24% | ||
1-Year Change | 25.99% | ||
3-Year Change | 46.40% | ||
5-Year Change | 194.31% | ||
Fundamentals | |||
Shares Outstanding | 253.5M | ||
Total Assets | $32.7B | ||
Market Cap | $138.7B | ||
Enterprise Value | $138.2B | ||
Period: QTR TTM FY | |||
Revenue | $3.4B | ||
Net Income | $653.6M | ||
Free Cash Flow | $545.8M | ||
EBIT | $783.4M | ||
EBITDA | $852.6M | ||
Net Working Capital | $6.7B | ||
EPS | $2.56 | ||
Enterprise Value/EBITDA | 162 | ||
Enterprise Value/Revenue | 40 | ||
P/B | 7 | ||
P/E | 214 | ||
PEG | -5 | ||
Price/Free Cash Flow | 254 | ||
Price/Operating Cash Flow | 216 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue